NCT00000274已完成2 期
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Side effects
研究概览
简要总结
The purpose of this study is to evaluate the safety and efficacy of flupenthixol and haloperidol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Side effects
Drug use
Psychiatric symptoms
Cocaine craving
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1Cocaine-Related DisordersNCT00000266National Institute on Drug Abuse (NIDA)
Unknown
1 期
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14Cocaine-Related DisordersNCT00000349National Institute on Drug Abuse (NIDA)
已完成
2 期
Naltrexone in Treatment of Cocaine Dependence - 5Cocaine-Related DisordersNCT00015080National Institute on Drug Abuse (NIDA)
Unknown
1 期
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1Cocaine-Related DisordersDrug Administration ScheduleInfusions, IntravenousNCT00033046National Institute on Drug Abuse (NIDA)12
已完成
2 期
Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5Cocaine-Related DisordersSubstance-Related DisordersNCT00015223National Institute on Drug Abuse (NIDA)